Ye Zeng
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation
Papers in
-
- RNA modifications and cancer 11
- Oncology 41
- Lung Cancer Research Studies 16
- Pancreatic and Hepatic Oncology Research 16
- Co-authors
- John M. Tarbell (8 shared papers)Bingmei M. Fu (11 shared papers)Xiaoheng Liu (18 shared papers)Xiaowu Xu (36 shared papers)Shunrong Ji (35 shared papers)Yi Qin (32 shared papers)Xianjun Yu (32 shared papers)Xinghong Yao (12 shared papers)
- Journals
- Cellular and Molecular Biology (6 papers)Acta Biochimica et Biophysica Sinica (5 papers)Oncogene (5 papers)The FASEB Journal (5 papers)Frontiers in Cell and Developmental Biology (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ye Zeng
134 papers receiving 3.6k citations
Ye Zeng's Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 1.3k
- Critical Care and Intensive Care Medicine 401
- Cell Biology 485
- Molecular Biology 1.9k
- Oncology 632
Countries citing papers authored by Ye Zeng
This map shows the geographic impact of Ye Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Zeng more than expected).
Fields of papers citing papers by Ye Zeng
This network shows the impact of papers produced by Ye Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Zeng. The network helps show where Ye Zeng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ye Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 212 | |
| 2 | 2018 | 162 | |
| 3 | 2014 | 135 | |
| 4 | 2021 | 118 | |
| 5 | 2019 | 114 | |
| 6 | Lactate‐induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer Hit paper breakdown → | 2023 | 107 |
| 7 | 2012 | 105 | |
| 8 | 2018 | 103 | |
| 9 | 2021 | 100 | |
| 10 | 2022 | 93 | |
| 11 | 2020 | 93 | |
| 12 | 2019 | 91 | |
| 13 | 2016 | 90 | |
| 14 | 2017 | 90 | |
| 15 | 2013 | 80 | |
| 16 | 2018 | 75 | |
| 17 | 2015 | 73 | |
| 18 | Abrogation of ARF6 promotes RSL3-induced ferroptosis and mitigates gemcitabine resistance in pancreatic cancer cells. | 2020 | 73 |
| 19 | 2019 | 68 | |
| 20 | 2020 | 56 |
About Ye Zeng
Ye Zeng is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Cell Biology, having authored 144 papers that have together received 3.6k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (18 papers), Lung Cancer Research Studies (16 papers), Pancreatic and Hepatic Oncology Research (16 papers), MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (11 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Neuroblastoma Research and Treatments (11 papers). The work is most often cited by research in Cancer Research (1.3k citations), Critical Care and Intensive Care Medicine (401 citations), Cell Biology (485 citations), Molecular Biology (1.9k citations) and Oncology (632 citations). Ye Zeng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include John M. Tarbell, Bingmei M. Fu, Xiaoheng Liu, Xiaowu Xu, Shunrong Ji, Yi Qin, Xianjun Yu, Xinghong Yao, Qifeng Zhuo and R. H. Adamson. Their work appears in journals such as Cellular and Molecular Biology, Acta Biochimica et Biophysica Sinica, Oncogene, The FASEB Journal and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.